Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
ROCKVILLE, Md., 2013-07-31 08:00 CEST (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the number of shares and warrants tendered to it in its recommended public offer to acquire all issued and outstanding shares and warrants (warrants series 2005-I and 2005-II) of Isconova AB ('Isconova'), which was first communicated on June 4, 2013, (the 'Offer').
Help employers find you! Check out all the jobs and post your resume.
ROCKVILLE, Md., 2013-07-31 08:00 CEST (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the number of shares and warrants tendered to it in its recommended public offer to acquire all issued and outstanding shares and warrants (warrants series 2005-I and 2005-II) of Isconova AB ('Isconova'), which was first communicated on June 4, 2013, (the 'Offer').
Help employers find you! Check out all the jobs and post your resume.
